03/23/2026 | Press release | Distributed by Public on 03/23/2026 15:28
Fierce Biotech explores how rising helium prices amid geopolitical tensions in the Middle East are impacting MRI providers and the broader medical imaging supply chain. The article notes that while disruptions to global helium supply, particularly from Qatar, are driving price volatility, U.S. providers have not yet experienced significant shortages due to domestic production and diversified sourcing.
Insights from Kyle MacKinnon, senior director of operational excellence at Premier, and Mark Hendrickson, director of supply chain policy at Premier, highlight the importance of supply chain resilience, long-term contracts and proactive planning as providers navigate ongoing uncertainty.
Read the full story on Fierce Biotech.